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The incidence of vomiting is also less . Propofol causes dose dependent depression of ventilation and pain on injection.
Etomidate was introduced in 1972. It is a carboxylated imidazole that is characterized by its hemodynamic stability. It is the inducing agent of choice in cardiac patients as it does not exert any effect on sympathetic nervous system and 2 increases coronary perfusion .
There are lot of studies that compare etomidate and propofol but results vary, here in this study we are comparing the effects of these drugs when it is given along with nalbuphine. This study aims to attempt to compare the hemodynamic parameters onset and efficacy of these combinations and adverse effects.
The onset of action of propofol is around 45 sec, that is one arm brain circulation time and last for 3-5 min. Decrease in action 3 of propofol is by redistribution to fat and muscles .
Etomidate onset of action is around 1 min and last for 5-15 min. Many studies have considered etomidate as an effective and 2 reliable sedation option with minimal side effects .
MATERIAL AND METHODS:
After approval from institutional ethical and scientific committee and after written and fully informed consent of 60 patients belonging to ASA grade I and II of either sex undergoing major surgeries under general anesthesia were included in our study. T he study was prospective observational study, 60 patients was randomized equal into two groups to receive either propofol with nalbuphine or etomidate with nalbuphine. 3. Hypotensive patients. 4. Patients presenting with any primary or secondary steroid deficiency or receiving any steroid medication.
Pregnant patient
All patients were visited preoperatively and pre anesthesia check up was completed, present history, past history, allergic history, physical examination and laboratory examinations were done including ECG.
Using computer generated randomization; patients were allotted into two groups comprising 30 each Group "P" and group "E" All patients were kept NPO for 8 hour, pre-medicated with inj ranitidine 50 mg IV. On reaching the operation theater electrocardiogram, non-invasive blood pressure, oxygen saturation and temperature were recorded. Ringer's lactate was started after securing a 20 G intravenous cannula. Glycopyrr olate 0.2 mg, midazolam 0.02 mg/kg and nalbuphine 0.1 mg/kg I.V. were injected followed by an induction dose of either propofol 1.5 mg/kg or etomidate0.2 mg / kg. Vecuronium 0.08 mg/kg intravenous given and approximately 3 minutes after trachea was intubated with appropriate sized endotracheal tube.
The position of endotracheal tube was confirmed and positive pressure ventilation was initiated. Anesthesia was maintained with oxygen and nitrous oxide at the ratio of 1:3 with isoflurane and intermittent doses of vecuronium .was given throughout the surgery as required. The reversal of the neuromuscular block was done by 0.05 mg/kg neostigmine and 0.01 mg/kg glycopyrrolate intravenously and the patient was extubated after adequate respiration and when the patient was able to follow verbal commands.
Blood pressure both systolic and diastolic, mean blood pressure and heart rate were monitored.
All the parameters were noted at baseline, induction, 1min, 3min, 5min, and 10 min.
Pain on injection site, Apnea, and myoclonus were noted. The obtained results were sent for statistical analysis. P value less than 0.05 was considered significant.
RESULTS
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DISCUSSION
Etomidate is a cardio stable agent but causes adrenocortical suppression and propofol is alkyl phenol agent that decreases arterial blood pressure. Hypotension occurs with propofol is mainly due to reduction of sympathetic activity causing vasodilation or its direct effect on vascular smooth 4 muscles .
Almost all studies that are published are based on fentanyl, which is why we decided to conduct this study with nalbuphine instead of fentanyl.
In this study all patients were premedicated with inj ranitidine 50 mg IV, inj Glycopyrrolate 0.2 mg IV, inj midazolam 0.02 mg/kg iv and inj nalbuphine 0.1 mg/kg iv. Followed by an induction dose of either inj propofol 1.5 mg/kg IV or inj etomidate 0.2 mg / kg IV. Inj vecuronium 0.08 mg/kg intravenous was given and appropriate sized endotracheal tube was used to intubate trachea. Systolic blood pressure, diastolic blood pressure, mean blood pressure and heart rate were monitored.
All the parameters were noted at baseline, induction, 1min, 3min, 5min, and 10 min. Compilations and adverse effects were also noted.
We made sure that parameters such as age, sex ASA grading, weight, baseline blood pressure and baseline heart rate were not significantly different.
As per our observation there was sustained increase in the heart rate throughout induction and intubation in propofol group while etomidate kept the heat rate stable .other studies also found that propofol had both direct myocardial depression and decreased systemic vascular resistance . This has been implicated in producing profound hypotension 5 following large bolus doses of propofol .
The variations in the systolic, diastolic and mean blood pressure were greater in propofol group than in the etomidate 6 group. Variations in the blood pressure may be mutifactorial .
Adverse effects such as pain, apnea and myoclonic jerks have been noticed. Pain was recorded more in propofol group that 7 is in line with various other studies like Wu et al and yogesh 6 kumar . Incidence of apnea was equal in both groups. Myoclonic jerks were more in etomidate group. Myoclonic jerks were common in etomidate group in studies conducted 8 9 by yogesh kumar, Miner et al and Desai et al .
CONCLUSION
In our study etomidate group had stable hemodynamic features than propofol group. There was significant difference in the baseline and post induction hemodynamics of the propofol group but the etomidate group had hemodynamics which was non -significant.
